Watch replays of the main stage programming from the SOSV Climate Tech Summit (Nov. 5-6)

Fast and affordable enzyme development platform

GET CONNECTED
allozymes.com

Team

Peyman Salehian

CEO

Akbar Vahidi

CTO

Shaun Sum

Head of Finance

Raine Koh

Head of Finance

Allozymes

Company details

Allozymes is building a platform to discover and scale novel enzymes powered by microfludics.

Climate TechHuman HealthSingaporeSeedClimate TechHard TechHealthcareHuman HealthHAX 2019

Company News

Syensqo and Allozymes to Develop Biosolutions for Home and Personal Care

July 5, 2024

Allozymes puts its accelerated enzymatics to work on a data and AI play, raising $15M

May 3, 2024
TechCrunch

Deals in brief: Oladance, BintanGo, and Allozymes secure new funding, and more | KrASIA

August 7, 2023
KrASIA

SG-based startup Allozymes secures capital from Xora Innovation, Seventure, others

August 7, 2023
DealStreetAsia

GenScript, Allozymes Partner To Advance Enzyme Discovery And Development

December 8, 2022
Contract Pharma

Get In Touch with Allozymes

Please tell us a little bit about yourself and why you'd like to get connected. Allozymes + SOSV will follow up with you via email.

Hidden
Hidden
Hidden
Hidden
Opt-in checkbox


We don’t spam. Our Privacy Policy and Terms of Use apply.
* If you are interested in investing directly into SOSV's portfolio of privately held companies, or into SOSV's funds, you need to meet the SEC’s criteria for accredited investor status. As an individual, you can qualify as an accredited investor by either (a) having more than $200,000 in annual income for each of the past two years (or $300,000 with your spouse) and a reasonable expectation of earning the same this year or (b) having a net worth of at least $1 million (not including your principal residence). Learn More